Multiple Myeloma

Drug makers fuming at ‘overpriced’ values placed on their myeloma drugs
Stat
Mon, 05/16/16 - 03:55 pm
Multiple Myeloma
Amgen
Kyprolis
How Takeda Is Changing The Face Of Myeloma Treatment
Seeking Alpha
Sat, 05/7/16 - 01:19 pm
Takeda
Multiple Myeloma
Ninlaro
Amgen's Kyprolis stands its ground against new J&J, BMS rivals
Fierce Pharma
Wed, 05/4/16 - 09:48 am
Amgen
Kyprolis
JNJ
Bristol-Myers Squibb
Multiple Myeloma
Darzalex
Empliciti
AbbVie
Takeda
Ninlaro
New myeloma meds work better than the old, but they're far too expensive: Report
Fierce Biotech
Tue, 04/12/16 - 03:39 pm
Multiple Myeloma
Bristol-Myers Squibb
Amgen
Takeda
Empliciti
Kyprolis
Ninlaro
Celgene
Revlimid
Amgen balks over meeting to review cost of bone cancer drugs
Stat
Thu, 04/7/16 - 09:46 am
Amgen
drug pricing
Kyprolis
Multiple Myeloma
Amgen launches Kyprolis in the UK for multiple myeloma
BioPharma Dive
Thu, 02/18/16 - 05:48 pm
Amgen
Kyprolis
UK
Multiple Myeloma
Celgene Corporation to Continue Dominating Myeloma Market
Bidness, ETC
Wed, 12/30/15 - 11:14 am
Celgene
Multiple Myeloma
Revlimid
Bristol Myers’s Empliciti Receives FDA Approval
Yahoo/Market Realist
Tue, 12/15/15 - 09:47 am
Bristol-Myers Squibb
Empliciti
FDA
Multiple Myeloma
Bluebird, Celgene See Promise in T Cell Therapy for Multiple Myeloma
TheStreet.com
Sat, 12/5/15 - 12:37 pm
Bluebird Bio
Celgene
t cell therapy
Multiple Myeloma
Can Bristol-Myers Squibb And AbbVie's Empliciti Become a Top Seller?
Motley Fool
Tue, 12/1/15 - 01:18 pm
AbbVie
Bristol-Myers Squibb
Empliciti
Multiple Myeloma
Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen
Motley Fool
Wed, 11/25/15 - 01:20 pm
JNJ
FDA
Amgen
Darzalex
daratumumab
Multiple Myeloma
FDA approves 3rd multiple myeloma med of 2015, Takeda's Ninlaro
BioPharma Dive
Mon, 11/23/15 - 01:19 pm
FDA
Takeda
Ninlaro
Multiple Myeloma
Takeda's 'breakthrough' Velcade heir wins early FDA approval in myeloma
Fierce Biotech
Fri, 11/20/15 - 06:20 pm
Takeda
Velcade
FDA
ixazomib
Multiple Myeloma
J&J nabs an early OK for 'breakthrough' multiple myeloma blockbuster contender Darzalex
Fierce Biotech
Mon, 11/16/15 - 03:29 pm
JNJ
Multiple Myeloma
daratumumab
FDA
Darzalex
Genmab
Spectrum says U.S. FDA declines to approve Evomela for injection
Yahoo/Reuters
Sat, 10/24/15 - 03:37 pm
FDA
Spectrum Pharmaceuticals
Evomela
Multiple Myeloma
FDA Grants Priority Review for Amgen's Supplemental New Drug Application for Expanded Labeling of Kyprolis® (Carfilzomib) in Relapsed Multiple Myeloma
Yahoo
Fri, 09/18/15 - 09:17 pm
FDA
Kyprolis
Amgen
Multiple Myeloma
Will Bristol-Myers (BMY) Stock Be Helped by Myeloma Gaining FDA Priority Review Approval?
TheStreet.com
Tue, 09/1/15 - 06:46 pm
Bristol-Myers Squibb
priority review
FDA
Multiple Myeloma
Empliciti
Bristol-Myers and AbbVie speed toward FDA approval with a 'breakthrough' cancer drug
Fierce Biotech
Tue, 09/1/15 - 06:38 pm
AbbVie
Bristol-Myers Squibb
FDA
elotuzumab
Multiple Myeloma
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
JNJ
daratumumab
Multiple Myeloma
Kyprolis
Amgen
Genmab
elotuzumab
AbbVie
Bristol-Myers Squibb
Amgen wins new myeloma nod for blockbuster hopeful Kyprolis
Fierce Pharma
Mon, 07/27/15 - 01:46 pm
Amgen
Multiple Myeloma
Kyprolis
Celgene
Pomolyst

Pages